The phase 2b SYMMETRY trial, a multicenter, randomized, double-blind, placebo-controlled study, included 181 patients with compensated cirrhosis (Child-Pugh A) due to MASH (78% with histological diagnosis and 22% with cryptogenic cirrhosis attributed to MASH) assigned to receive efruxifermin at doses of 28 or 50 mg, or placebo (1:1:1), for 96 weeks
Many turn to supplements in the hope of finding a natural way to support their health
Discount applied at checkout Science Backed
Whether youre looking to transition off GLP-1 medications, optimize fat loss, or simply find a better way to satisfy your sweet tooth , allulose offers an intriguing evidence-based approach
Electrolyte Support: Supplement with ReMineralize and e-lyte to maintain optimal electrolyte and mineral balance before, during, and after your sauna session
Danuglipron is a GLP-1 receptor agonist A GLP-1 receptor agonist is a type of medication that mimics the actions of a hormone called glucagon-like peptide-1 (GLP-1)